News from allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

02 Apr, 2020, 12:30 BST China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel...


24 Jul, 2019, 13:37 BST Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders

Allergan plc (NYSE: AGN) today announced a voluntary worldwide recall of BIOCELL® textured breast implants and tissue expanders. Allergan is taking...


04 Apr, 2019, 14:00 BST Allergan launches Juvéderm® VOLUX - the latest evolution in facial filler treatments for those seeking a more defined chin and jawline

Allergan plc (NYSE: AGN) –– today launched Juvéderm® VOLUX at the 17th Aesthetic & Anti-Aging World Congress (AMWC) in Monaco. Juvéderm® VOLUX...


07 Mar, 2019, 17:54 GMT Allergan Launches "Beauty Decoded Live" Event Series in London

-- Beauty Decoded Live aims to build consumer confidence and increase knowledge when considering a medical aesthetic treatment -- -- Beauty Decoded...


19 Dec, 2018, 13:41 GMT Allergan Suspends Sales and Withdraws Supply of Textured Breast Implants in European Markets

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that the company has suspended sales of textured breast...


19 Apr, 2018, 20:13 BST Statement regarding Shire plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...


06 Apr, 2018, 08:00 BST Allergan Presents Results From Global Survey Highlighting the Importance of Trust in Medical Aesthetics

Allergan plc (NYSE: AGN) announced during the 16th Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monte Carlo, Monaco, results of its...


22 Mar, 2018, 07:00 GMT Ozurdex® (dexamethasone 0.7mg) now available for millions of patients in China with macular edema secondary to retinal vein occlusion

Today, Allergan plc (NYSE:AGN) announces the launch of Ozurdex® (dexamethasone intravitreal implant 0.7 mg) in China for the treatment of adult...


10 May, 2017, 08:00 BST Allergan Announces Tender Offers by Certain Subsidiaries

Allergan plc (NYSE: AGN) today announced that its indirectly wholly owned subsidiaries Allergan Funding SCS, Allergan Finance LLC, Forest...


10 May, 2017, 08:00 BST Allergan Announces Proposed Public Offering of Senior Notes to Refinance Existing Debt

Allergan plc (NYSE: AGN) ("Allergan" or the "Company") today announced that, subject to market and other conditions, the Company expects to commence...


09 Mar, 2017, 19:00 GMT Allergan plc Question if a Feminist Can Love Fillers?

Debate hosted by Cosmetic Executive Women and Allergan Panellists questioned if 'Lying about your treatment is the new lying about your age?' and...


27 Jan, 2017, 07:40 GMT Allergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months

-- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] ...


13 Oct, 2016, 12:00 BST Allergan's BELKYRA® (Deoxycholic Acid) Receives Marketing Authorisation In Sweden For The Treatment Of Moderate To Severe Fullness Under The Chin (Double Chin)

-- BELKYRA® is an individually-tailored, injectable treatment that permanently destroys fat cells under the chin(1) -- -- More than 67 per cent of...


01 Jul, 2016, 12:30 BST Allergan Receives Positive Opinion Through European Decentralised Procedure For BELKYRA® (Deoxycholic Acid) For Patients With Submental Fullness

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has received a Positive Opinion from the Swedish Medical...


28 Jun, 2016, 12:00 BST New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth

Allergan plc (NYSE: AGN), a global medical aesthetics company and the makers of Juvéderm® facial fillers today announces the results of a new global...


29 Apr, 2016, 14:24 BST Allergan Receives CHMP Positive Opinion For ENZEPI® (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) has ...


03 Sep, 2015, 22:46 BST Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on...